T78.41XA Arthus phenomenon, initial encounter

Name of the Condition

• Arthus phenomenon, initial encounter (ICD-10 Code: T78.41XA)

Summary

This code documents an initial encounter for the Arthus phenomenon, a localized hypersensitivity reaction characterized by immune complex-mediated inflammation. It is typically associated with repeated exposure to an antigen, leading to tissue damage at the site of injection or exposure.

Causes

The Arthus phenomenon occurs when the immune system forms antigen-antibody complexes that deposit in small blood vessels, triggering an inflammatory response. Common triggers include vaccinations, medications, or other substances administered via injection, where repeated exposure leads to immune complex formation.

Risk Factors

• Prior exposure to the causative antigen (e.g., vaccine, medication)
• High antigen concentration or frequent dosing
• Underlying immune system dysregulation
• History of similar hypersensitivity reactions

Symptoms

• Localized swelling, redness, or induration at the exposure site
• Pain or tenderness in the affected area
• Possible skin necrosis or ulceration in severe cases
• Systemic symptoms (e.g., fever) are rare but may occur

Diagnosis

Diagnosis is based on clinical presentation and history of antigen exposure. Laboratory tests (e.g., serum antigen-antibody levels) may support the diagnosis, but confirmation often relies on correlating symptoms with the timing and nature of exposure.

Treatment Options

• Local cooling or anti-inflammatory measures for mild cases
• Corticosteroids to reduce inflammation
• Antihistamines for symptom relief
• Avoidance of the causative antigen to prevent recurrence

Prognosis and Follow-Up

Most cases resolve with treatment, though tissue damage may persist in severe instances. Follow-up focuses on monitoring for complications and educating patients on antigen avoidance to prevent future reactions.

Complications

• Tissue necrosis or scarring at the exposure site
• Secondary infection of damaged tissue
• Rare progression to systemic immune complex disease

Lifestyle & Prevention

• Avoid known triggering antigens (e.g., specific medications or vaccines)
• Inform healthcare providers of prior hypersensitivity reactions
• Use alternative formulations or routes of administration when possible

When to Seek Professional Help

Seek immediate care if symptoms worsen, spread, or include systemic signs (e.g., fever, widespread rash), as these may indicate a more severe reaction requiring urgent intervention.

Tips for Medical Coders

Document the initial encounter context and specify the causative antigen if known. Ensure the code aligns with the timing of the reaction (initial encounter) and the clinical evidence of immune complex-mediated inflammation.